'A new window on the brain'
may inform evidence-based
drug development

Hyperpolarized xenon-MR Alzheimer's brain study gets new funding

June 22, 2016
by Thomas Dworetzky, Contributing Reporter
The Weston Brain Institute in Canada will put over $700,000 into new Alzheimer's research using hyperpolarized xenon gas MR scanning techniques. The money will fund the first large-scale clinical trial in the world using the gas to take brain images.

Dr. Mitchell Albert, a researcher and chemistry professor at Lakehead University and the Thunder Bay Regional Research Institute is spearheading the three-year effort. Albert co-invented hyperpolarized gas MR while in graduate school at the State University of New York at Stony Brook. He has been on the faculty of Harvard Medical School and the University of Massachusetts Medical School, and joined Thunder Bay and Lakehead in 2011.

The use of hyperpolarized xenon MR should “provide a more sensitive measurement of brain function in Alzheimer’s patients,” Albert said in a statement by the university.

“It’s a new window on the brain,” he told Lokalee.com, adding, “No one has looked at these images before. We don’t know what we’re going to see. So, it’s very, very exciting.”

In addition, the research will offer advantages for testing new treatments for the condition – especially drug testing. “The enhanced detection capabilities of our hyperpolarized technique with MR will encourage an evidence-based approach to drug development, since more people will want to participate in clinical trials,” he advised, adding that this will also aid in the evaluation of new drugs.

“If successful, Dr. Albert’s imaging tools will have great impact in developing effective treatments for Alzheimer’s disease,” said Alexandra Stewart, executive director at the Weston Brain Institute.

A 2014 International Innovation interview with Albert about his work discussed the advantages that come from combining hyperpolarized gas with MR.

These include:

Specific advantages of hyperpolarizing Xenon MR include:


Albert became interested in xenon and MR while still in graduate school. “I ended up going to graduate school for chemistry and, because I wanted to work on a new imaging modality for the brain, I majored in physical chemistry,” he told the publication.

He then joined a nuclear magnetic resonance group at the State University of New York at Stony Brook that was involved with MR. “For one of my projects, I began researching xenon. This led me to postulate that using xenon to study the brain could simplify the imaging process, as it doesn’t form bonds with other elements and alleviates complications.”

Now, thanks to the funding for his work at Weston, he is able to pursue the research that began decades ago.

“I collaborated with Professor Gordon Cates and his research group at Princeton University,” he recounted in his 2014 interview. “We used an optical pumping system to inflate mouse lungs with hyperpolarized (HP) xenon, and published our findings in Nature in 1994. This was the first demonstration of HP gas imaging of any kind. We chose to image the lungs because that’s where the signal would be highest after inhaling the gas. We then had the idea to move onto the brain – my main interest at the time. Now, however, 20 years later, we are just beginning to image the brain.”